Patents Assigned to Dana-Farber Camcer Institute, Inc.
  • Publication number: 20160340407
    Abstract: The present invention relates to compositions and methods for identifying, assessing, preventing, and treating melanoma, A variety of PD-L1 isoform biomarkers are provided, wherein alterations in the copy number of one or more of the biomarkers and/or alterations in the amount, structure, and/or activity of one or more of the biomarkers is associated with melanoma status.
    Type: Application
    Filed: January 14, 2015
    Publication date: November 24, 2016
    Applicant: Dana-Farber Camcer Institute, Inc.
    Inventors: F. Stephen Hodi, Jun Zhou, Gordon J. Freeman, Jingjing Li, Xinqi Wu